Fabrizio Colombo

Fabrizio Colombo

Auto-generated profile, based on publicly available information

Fabrizio Colombo

Division of Internal Medicine 1, Multispecialist Medical Department, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
APArianna Pani
Arianna Pani
FCFabrizio Colombo
Fabrizio Colombo
FAFrancesca Agnelli
Francesca Agnelli
VFViviana Frantellizzi
Viviana Frantellizzi
FBFrancesco Baratta
Francesco Baratta
Francesco ScaglioneFrancesco Scaglione
Francesco Scaglione

1 December 1998 in The Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
RPRossella Parini
Rossella Parini
FCF. Colombo
F. Colombo
Andrea LombardiAndrea Lombardi
Andrea Lombardi
MFMenni FRANCESCA
Menni FRANCESCA
LBL. Beccaria
L. Beccaria

3 May 2018 in The Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
FCFabrizio Colombo
Fabrizio Colombo
PNPietro Nunnari
Pietro Nunnari
GCGiovanni Ceccarelli
Giovanni Ceccarelli
ARAngelo Valerio Romano
Angelo Valerio Romano
PBPietro Barbieri
Pietro Barbieri
FSFrancesco Scaglione
Francesco Scaglione

29 May 2021 in medRxiv
Verified
Preprint
Open access
PDF file
NUNicola Ughi
Nicola Ughi
AAAntonella Adinolfi
Antonella Adinolfi
MCMichel Chevallard
Michel Chevallard
LBLaura Belloli
Laura Belloli
MSMichele Senatore
Michele Senatore
OEOscar Massimiliano Epis
Oscar Massimiliano Epis
Background An urgent need exists for an early detection of cases with a high-risk of SARS-CoV-2 infection, particularly in high-flow and -risk settings, such as emergency departments (EDs). The aim of this work is to develop and validate a predictive model for the evaluation of SARS-CoV-2 infection risk, with the rationale of using this tool to manage ED patients. Methods A retrospective study was performed by cross-sectionally reviewing the electronical case records of patients admitted to Niguarda Hospital or referred to its ED in the period 15 March to 24 April 2020. Derivation sample was composed of non-random inpatients hospitalized on 24 April and admitted before 22 April 2020. Validation sample was composed of consecutive patients who visited the ED between 15 and 25 March 2020. The association between the dichotomic outcome and each predictor was explored by univariate analysis with logistic regression models. Results A total of 113 patients in the derivation sample and 419 in the validation sample were analyzed. History of fever, elder age and low oxygen saturation showed to be significant predictors of SARS-CoV-2 infection. The neutrophil count improves the discriminative ability of the model, even if its calibration and usefulness in terms of diagnosis is unclear. Conclusion The discriminatory ability of the identified models makes the overall performance suboptimal; their implementation to calculate the individual risk of infection should not be used without additional investigations. However, they could be useful to evaluate the spatial allocation of patients while awaiting the result of the nasopharyngeal swab. What is already known on this topic 1 year after the onset of the coronavirus disease 2019 (COVID-19) pandemic, the trend of its spread has not shown a substantial global reduction. An urgent need exists for efficient early detection of cases with a high risk of SARS-CoV-2 infection and a number of diagnostic prediction models have been developed, but a few models were externally validated in high-flow and –risk settings, such as emergency departments (EDs). What this study adds This study develops and validate predictive models for the evaluation of SARS-CoV-2 infection risk, with the rationale of using these tools to promptly manage patients who are afferent to the ED, allocating them accordingly to the risk of infection while awaiting swab result. History of fever, older age and low oxygen saturation showed to be significant predictors of the presence of SARS-CoV-2 infection. The use of laboratory findings, such as neutrophil count, showed to improve the discriminative ability of the model, even if its calibration and usefulness in terms of diagnosis is unclear.

1 January 2022 in Archives of Clinical and Medical Case Reports
Verified
Journal Article
Open access
PDF file
MAMaria Gloria Aversano
Maria Gloria Aversano
GLGiovanni Lasagni
Giovanni Lasagni
FCFabrizio Colombo
Fabrizio Colombo
YAYuri Alessandro Arguello
Yuri Alessandro Arguello
LBLuca Giuseppe Balossi
Luca Giuseppe Balossi
Eosinophilic Granulomatosis with Polyangiitis (EGPA), commonly known in the past as Churg-Strauss syndrome, is a necrotizing systemic vasculitis accompanied by remarkable eosinophilia. Heart involvement occurs in approximately 15-60% of EGPA patients, especially those who are ANCA negative. Any cardiac structure can be involved. Heart involvement carries a poor prognosis and causes 50% of the deaths of these patients. It is often insidious and underestimated. Early diagnosis of cardiac involvement and subsequent therapy may prevent progression of cardiac disease. To our knowledge, so far there are only few cases reported in the literature describing pericarditis as a presenting feature of EGPA. Here we report a case of a 54- year- old male with history of repeated sinusitis and mild asthma admitted to our department for worsening dyspnea and chest pain with consequent diagnosis of acute pericarditis due to unknown EGPA. This case suggests that acute pericarditis can be the initial clinical feature of onset EGPA, even in patients with mild asthma history. Early diagnosis of cardiac involvement prevents progression of cardiac disease.

1 January 2022 in Archives of Clinical and Medical Case Reports
Verified
Journal Article
Open access
PDF file
MAMaria Gloria Aversano
Maria Gloria Aversano
ABAlice Botta
Alice Botta
MSMatteo Sbattella
Matteo Sbattella
LBLuca Giuseppe Balossi
Luca Giuseppe Balossi
FCFabrizio Colombo
Fabrizio Colombo
Antiphospholipid Syndrome (APS) is a condition characterized by clinical features of thrombosis and repeated miscarriages (criteria manifestations) accompanied by presence of antiphospholipid antibodies on laboratory tests. APS is a disease that can also present different clinical manifestations (non-criteria manifestations), including livedo reticularis, cutaneous ulcerations, thrombocytopenia, hemolytic anemia, valvular heart disease, and nephropathy, for which the gold standard treatment is often not known. Most of the APS management guidelines focus on the prevention and treatment of thrombotic and obstetrical manifestations, by anticoagulant therapy. However there is less consensus on the gold standard treatment for other clinical manifestations, which can have a serious impact on the health of the affected patient. Here we present a case report that emphasizes the importance of identifying correct therapy for non-criteria clinical manifestations of APS triggered by post-traumatic left fronto-temporal hematoma, subsequent neurosurgical intervention complicated by subdural empyema.